{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:19:37Z","timestamp":1792091977854,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204849"],"award-info":[{"award-number":["82204849"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113629","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T17:56:38Z","timestamp":1732211798000},"page":"113629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Taoren Honghua Decoction alleviates atherosclerosis by inducing autophagy and inhibiting the PI3K-AKT signaling pathway to regulate cholesterol efflux and inflammatory responses"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4694-1984","authenticated-orcid":false,"given":"Xindi","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoteng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.intimp.2024.113629_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713434","article-title":"Novel Insights into the Molecular Mechanisms of Atherosclerosis","volume":"24","author":"Wojtasi\u0144ska","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.intimp.2024.113629_b0010","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/j.ymthe.2022.08.024","article-title":"Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations","volume":"30","author":"Hetherington","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.intimp.2024.113629_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: recent developments","author":"Bj\u00f6rkegren","year":"2022","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.intimp.2024.113629_b0020","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.numecd.2022.04.024","article-title":"Subclinical atherosclerosis in adolescents and young adults and the risk of cardiovascular disease: The Strong Heart Family Study (SHFS)","volume":"32","author":"Reese","year":"2022","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"8","key":"10.1016\/j.intimp.2024.113629_b0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-021-00647-9","article-title":"Prevention of atherosclerosis from childhood","volume":"19","author":"Raitakari","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113629_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-011-0219-7","article-title":"Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges","volume":"14","author":"Sampson","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.intimp.2024.113629_b0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/JMDH.S54324","article-title":"Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment","volume":"7","author":"Cryer","year":"2014","journal-title":"J Multidiscip Healthc"},{"issue":"13","key":"10.1016\/j.intimp.2024.113629_b0040","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.115.018381","article-title":"Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT","volume":"132","author":"Bohula","year":"2015","journal-title":"Circulation"},{"issue":"03","key":"10.1016\/j.intimp.2024.113629_b0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1142\/S0192415X09006941","article-title":"New exploration and understanding of traditional Chinese medicine","volume":"37","author":"Xutian","year":"2009","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113629_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-13-132","article-title":"The quest for modernisation of traditional Chinese medicine","volume":"13","author":"Xu","year":"2013","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.intimp.2024.113629_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105168","article-title":"Traditional Chinese medicine in cardiovascular drug discovery","volume":"160","author":"Leung","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.intimp.2024.113629_b0060","article-title":"Effects of Taoren Honghua Jian on the hyperlipidemia without symptom, Chinese Journal of","author":"Chen","year":"2000","journal-title":"Pathophysiology"},{"key":"10.1016\/j.intimp.2024.113629_b0065","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3389\/fphar.2020.01070","article-title":"Taoren Honghua Drug Attenuates Atherosclerosis and Plays an Anti-Inflammatory Role in ApoE Knock-Out Mice and RAW264.7 Cells","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113629_b0070","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.bbrc.2019.04.134","article-title":"p62\/mTOR\/LXR\u03b1 pathway inhibits cholesterol efflux mediated by ABCA1 and ABCG1 during autophagy blockage","volume":"514","author":"Liang","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.intimp.2024.113629_b0075","article-title":"Role of PI3K in the Progression and Regression of Atherosclerosis","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113629_b0080","doi-asserted-by":"crossref","unstructured":"Z. Zhou, B. Chen, S. Chen, M. Lin, Y. Chen, S. Jin, W. Chen, Y. Zhang, Applications of Network Pharmacology in Traditional Chinese Medicine Research, Evidence-based complementary and alternative medicine : eCAM 2020 (2020) 1646905.","DOI":"10.1155\/2020\/1646905"},{"issue":"8","key":"10.1016\/j.intimp.2024.113629_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/biom9080362","article-title":"The Methodological Trends of Traditional Herbal Medicine Employing Network Pharmacology","volume":"9","author":"Lee","year":"2019","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.intimp.2024.113629_b0090","first-page":"110","article-title":"Traditional Chinese medicine network pharmacology: theory, methodology and application","volume":"11","author":"Shao","year":"2013","journal-title":"Chin. J. Nat. Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.113629_b0095","first-page":"798","article-title":"Protein-protein interactions: detection, reliability assessment and applications","volume":"18","author":"Peng","year":"2017","journal-title":"Brief Bioinform"},{"issue":"5081","key":"10.1016\/j.intimp.2024.113629_b0100","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E","volume":"258","author":"Zhang","year":"1992","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2024.113629_b0105","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/bab.2104","article-title":"The interplay of ROS and the PI3K\/Akt pathway in autophagy regulation","volume":"69","author":"Kma","year":"2022","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.intimp.2024.113629_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105187","article-title":"Current Policies and Measures on the Development of Traditional Chinese Medicine in China","volume":"163","author":"Wang","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.intimp.2024.113629_b0115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fphar.2020.00422","article-title":"Herbal Medicine for Cardiovascular Diseases: Efficacy","volume":"11","author":"Shaito","year":"2020","journal-title":"Mechanisms, and Safety, Frontiers in Pharmacology"},{"issue":"11","key":"10.1016\/j.intimp.2024.113629_b0120","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1002\/ptr.7590","article-title":"Therapeutic potential of traditional Chinese medicine in atherosclerosis: A review","volume":"36","author":"Liu","year":"2022","journal-title":"Phytother Res"},{"key":"10.1016\/j.intimp.2024.113629_b0125","article-title":"Bioactive Flavonoids in Protecting Against Endothelial Dysfunction and Atherosclerosis","author":"Yin","year":"2024","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.intimp.2024.113629_b0130","doi-asserted-by":"crossref","unstructured":"G. Liao, W. Liu, Y. Dai, X. Shi, Y. Liu, D. Li, T. Xu, Beneficial effects of flavonoids on animal models of atherosclerosis: A systematic review and meta-analysis, iScience 26(11) (2023) 108337.","DOI":"10.1016\/j.isci.2023.108337"},{"issue":"11","key":"10.1016\/j.intimp.2024.113629_b0135","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1002\/ptr.7962","article-title":"Apigenin inhibits macrophage pyroptosis through regulation of oxidative stress and the NF-\u03baB pathway and ameliorates atherosclerosis","volume":"37","author":"Weng","year":"2023","journal-title":"Phytother Res"},{"key":"10.1016\/j.intimp.2024.113629_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120064","article-title":"The protective effect of quercetin on macrophage pyroptosis via TLR2\/Myd88\/NF-\u03baB and ROS\/AMPK pathway","volume":"291","author":"Luo","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.intimp.2024.113629_b0145","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.biopha.2016.11.077","article-title":"Quercetin attenuates high fructose feeding-induced atherosclerosis by suppressing inflammation and apoptosis via ROS-regulated PI3K\/AKT signaling pathway","volume":"85","author":"Lu","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.intimp.2024.113629_b0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jnutbio.2014.11.008","article-title":"Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing I\u039aB\u03b1\/NF-\u03baB signaling pathway","volume":"26","author":"Jia","year":"2015","journal-title":"J Nutr Biochem"},{"issue":"3","key":"10.1016\/j.intimp.2024.113629_b0155","first-page":"2593","article-title":"Luteolin decreases atherosclerosis in LDL receptor-deficient mice via a mechanism including decreasing AMPK-SIRT1 signaling in macrophages","volume":"16","author":"Li","year":"2018","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.intimp.2024.113629_b0160","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1080\/13880209.2021.1961823","article-title":"Kaempferol-induced GPER upregulation attenuates atherosclerosis via the PI3K\/AKT\/Nrf2 pathway","volume":"59","author":"Feng","year":"2021","journal-title":"Pharm Biol"},{"issue":"7","key":"10.1016\/j.intimp.2024.113629_b0165","first-page":"1459","article-title":"Supplementation of the Pure Flavonoids Epicatechin and Quercetin Affects Some Biomarkers of Endothelial Dysfunction and Inflammation in (Pre)Hypertensive Adults: A Randomized Double-Blind","volume":"145","author":"Dower","year":"2015","journal-title":"Placebo-Controlled, Crossover Trial, J Nutr"},{"issue":"8","key":"10.1016\/j.intimp.2024.113629_b0170","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1080\/10408398.2022.2121261","article-title":"Kaempferol and atherosclerosis: From mechanism to medicine","volume":"64","author":"Chen","year":"2024","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"10.1016\/j.intimp.2024.113629_b0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12872-019-01289-z","article-title":"Tanshinone IIA prevents platelet activation and down-regulates CD36 and MKK4\/JNK2 signaling pathway","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.intimp.2024.113629_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109729","article-title":"Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-\/-) mice by activating PI3K\/AKT signaling and suppressing TRL4\/NF-\u03baB signaling","volume":"123","author":"Wang","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10.1016\/j.intimp.2024.113629_b0185","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1166\/jbn.2023.3689","article-title":"Tanshinone IIA Alleviates Atherosclerosis Through Inhibition of NF-\u03baB and PPAR\u03b1\/ABCA1 Signaling Pathways","volume":"19","author":"He","year":"2023","journal-title":"J. Biomed. Nanotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113629_b0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/83348","article-title":"PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway","volume":"7","author":"Chinetti","year":"2001","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.intimp.2024.113629_b0195","first-page":"10854","article-title":"Quercetin increases macrophage cholesterol efflux to inhibit foam cell formation through activating PPAR\u03b3-ABCA1 pathway","volume":"8","author":"Sun","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.intimp.2024.113629_b0200","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2147\/DDDT.S288728","article-title":"Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPAR\u03b3-Integrin \u03b1(v)\u03b2(5) Signaling Pathway","volume":"15","author":"Zhang","year":"2021","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"10.1016\/j.intimp.2024.113629_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040844","article-title":"Hypaphorine Attenuates Lipopolysaccharide-Induced Endothelial Inflammation via Regulation of TLR4 and PPAR-\u03b3 Dependent on PI3K\/Akt\/mTOR Signal Pathway","volume":"18","author":"Sun","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.intimp.2024.113629_b0210","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/aps.2015.87","article-title":"The roles of macrophage autophagy in atherosclerosis","volume":"37","author":"Shao","year":"2016","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"10.1016\/j.intimp.2024.113629_b0215","doi-asserted-by":"crossref","first-page":"E530","DOI":"10.1152\/ajpendo.00640.2012","article-title":"Autophagy is involved in adipogenic differentiation by repressesing proteasome-dependent PPAR\u03b32 degradation","volume":"305","author":"Zhang","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.intimp.2024.113629_b0220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.intimp.2018.03.036","article-title":"Micheliolide alleviates hepatic steatosis in db\/db mice by inhibiting inflammation and promoting autophagy via PPAR-\u03b3-mediated NF-\u043aB and AMPK\/mTOR signaling","volume":"59","author":"Zhong","year":"2018","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"10.1016\/j.intimp.2024.113629_b0225","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1080\/15548627.2015.1043076","article-title":"Differential regulatory functions of three classes of phosphatidylinositol and phosphoinositide 3-kinases in autophagy","volume":"11","author":"Yu","year":"2015","journal-title":"Autophagy"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924021519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924021519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:37:19Z","timestamp":1789645039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924021519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":45,"alternative-id":["S1567576924021519"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113629","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Taoren Honghua Decoction alleviates atherosclerosis by inducing autophagy and inhibiting the PI3K-AKT signaling pathway to regulate cholesterol efflux and inflammatory responses","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113629","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113629"}}